Fluidigm Corporation (FLDM): Price and Financial Metrics

Fluidigm Corporation (FLDM): $3.71

-0.28 (-7.02%)

POWR Rating

Component Grades














  • Growth is the dimension where FLDM ranks best; there it ranks ahead of 91.43% of US stocks.
  • FLDM's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • FLDM ranks lowest in Momentum; there it ranks in the 14th percentile.

FLDM Stock Summary

  • FLDM has a market capitalization of $305,706,365 -- more than approximately 28.09% of US stocks.
  • As for revenue growth, note that FLDM's revenue has grown -5.47% over the past 12 months; that beats the revenue growth of only 13.25% of US companies in our set.
  • In terms of volatility of its share price, FLDM is more volatile than 83.96% of stocks we're observing.
  • Stocks that are quantitatively similar to FLDM, based on their financial statements, market capitalization, and price volatility, are BNGO, RCEL, OM, CTSO, and UPWK.
  • FLDM's SEC filings can be seen here. And to visit Fluidigm Corp's official web site, go to www.fluidigm.com.

FLDM Valuation Summary

  • In comparison to the median Healthcare stock, FLDM's price/earnings ratio is 125.21% lower, now standing at -9.2.
  • FLDM's price/sales ratio has moved down 6.6 over the prior 128 months.
  • FLDM's price/sales ratio has moved down 6.6 over the prior 128 months.

Below are key valuation metrics over time for FLDM.

Stock Date P/S P/B P/E EV/EBIT
FLDM 2021-08-31 3.7 5.0 -9.2 -10.6
FLDM 2021-08-30 3.7 5.0 -9.2 -10.6
FLDM 2021-08-27 3.6 4.9 -9.0 -10.5
FLDM 2021-08-26 3.6 4.9 -8.9 -10.4
FLDM 2021-08-25 3.7 5.0 -9.1 -10.5
FLDM 2021-08-24 3.7 5.0 -9.0 -10.5

FLDM Growth Metrics

    Its 4 year net income to common stockholders growth rate is now at 3.43%.
  • Its 3 year net cashflow from operations growth rate is now at 10.81%.
  • The 2 year net income to common stockholders growth rate now stands at 2.26%.
FLDM's revenue has moved up $12,754,000 over the prior 34 months.

The table below shows FLDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 130.581 -44.061 -59.237
2021-09-30 136.924 -40.792 -67.833
2021-06-30 148.281 -35.897 -59.989
2021-03-31 143.321 -24.023 -55.861
2020-12-31 138.144 -15.417 -53.02
2020-09-30 125.976 -17.203 -47.679

FLDM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • FLDM has a Quality Grade of C, ranking ahead of 27.63% of graded US stocks.
  • FLDM's asset turnover comes in at 0.477 -- ranking 50th of 76 Measuring and Control Equipment stocks.
  • FTV, NVMI, and ITRI are the stocks whose asset turnover ratios are most correlated with FLDM.

The table below shows FLDM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.477 0.587 -0.374
2021-03-31 0.464 0.599 -0.362
2020-12-31 0.453 0.603 -0.332
2020-09-30 0.434 0.595 -0.319
2020-06-30 0.407 0.566 -0.404
2020-03-31 0.414 0.555 -0.428

FLDM Price Target

For more insight on analysts targets of FLDM, see our FLDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $11.00 Average Broker Recommendation 1 (Strong Buy)

FLDM Stock Price Chart Interactive Chart >

Price chart for FLDM

FLDM Price/Volume Stats

Current price $3.71 52-week high $7.51
Prev. close $3.99 52-week low $2.67
Day low $3.66 Volume 527,300
Day high $4.05 Avg. volume 968,838
50-day MA $3.56 Dividend yield N/A
200-day MA $4.95 Market Cap 283.76M

Fluidigm Corporation (FLDM) Company Bio

Fluidigm Corporation develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. The company was founded in 1999 and is based in South San Francisco, California.

FLDM Latest News Stream

Event/Time News Detail
Loading, please wait...

FLDM Latest Social Stream

Loading social stream, please wait...

View Full FLDM Social Stream

Latest FLDM News From Around the Web

Below are the latest news stories about Fluidigm Corp that investors may wish to consider to help them evaluate FLDM as an investment opportunity.

Fluidigm Non-GAAP EPS of -$0.01 beats by $0.17, revenue of $38.27M beats by $5.57M

Fluidigm press release (NASDAQ:FLDM): Q4 Non-GAAP EPS of -$0.01 beats by $0.17. Revenue of $38.27M (-14.2% Y/Y) beats by $5.57M....

Seeking Alpha | February 17, 2022

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the fourth quarter and full year ended December 31, 2021.

GlobeNewswire | February 17, 2022

Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

Collaboration Enables Further Expansion of Mass Cytometry in the Middle EastSOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement with the Abu Dhabi Stem Cells Center (ADSCC) for development of targeted stem cell therapies and research applications utilizing two Fluidigm® mass cytometry and tissue im

Yahoo | February 17, 2022

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy statement for a special meeting of stockholders (the “Special Meeting”) at which Fluidigm stockholders will have the opportunity to consider and vote upon various items related to the proposed and previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC (“Casdi

Yahoo | February 14, 2022

Worldwide Spatial OMICS Industry to 2028 - Featuring 10x Genomics, NanoString Technologies and PerkinElmer Among Others - ResearchAndMarkets.com

The "Global Spatial OMICS Market, By Sample Type, By End Use, By Technology, By Product, By Workflow, Estimation & Forecast, 2018 - 2028" report has been added to ResearchAndMarkets.com''s offering. The global spatial OMICS market held a market value of USD 230.2 million in 2020 and is estimated to reach USD 506.6 million by the year 2028. The market is anticipated to register a CAGR of 10.3% during the forecast period. Companies Mentioned 10x Genomics S2 Genomics, Inc. NanoString Technologies Seven Bridges Genomics PerkinElmer, Inc. Bio-Techne Danaher Corporation IonPath, Inc. Millennium Science Pty Ltd Akoya Biosciences, Inc. Fluidigm Corporation Diagenode Diagnostics Biognosys AG Rebus Biosystems Ultivue, Inc. BioSpyder Technologies Bruker Spatial omics combines the molecular scrutin...

Benzinga | February 3, 2022

Read More 'FLDM' Stories Here

FLDM Price Returns

1-mo N/A
3-mo 5.70%
6-mo -18.10%
1-year -30.52%
3-year -68.34%
5-year -32.42%
YTD -5.36%
2021 -34.67%
2020 72.41%
2019 -59.63%
2018 46.35%
2017 -19.09%

Continue Researching FLDM

Want to see what other sources are saying about Fluidigm Corp's financials and stock price? Try the links below:

Fluidigm Corp (FLDM) Stock Price | Nasdaq
Fluidigm Corp (FLDM) Stock Quote, History and News - Yahoo Finance
Fluidigm Corp (FLDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7737 seconds.